AxoGen Inc.

NASDAQ: AXGN · Real-Time Price · USD
14.94
0.04 (0.27%)
At close: Aug 15, 2025, 3:59 PM
15.16
1.51%
After-hours: Aug 15, 2025, 07:57 PM EDT

AxoGen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
187.34M 159.01M 138.58M 127.36M
Cost of Revenue
45.36M 31.14M 24.15M 22.93M
Gross Profit
141.98M 127.87M 114.44M 104.43M
Operating Income
-3.29M -21.46M -29.71M -25.42M
Interest Income
n/a n/a n/a n/a
Pretax Income
-9.96M -21.72M -28.95M -26.98M
Net Income
-9.96M -21.72M -27.34M -28.06M
Selling & General & Admin
117.5M 121M 116.99M 105.67M
Research & Development
27.77M 28.33M 27.16M 24.18M
Other Expenses
n/a n/a -230K -278K
Operating Expenses
145.26M 149.34M 144.14M 129.84M
Interest Expense
8.21M 2.83M 624K 1.36M
Selling & Marketing Expenses
78.46M 86.06M 80.23M 73.33M
Cost & Expenses
190.63M 180.47M 168.29M 152.77M
Income Tax Expense
n/a n/a -1.61M 1.08M
Shares Outstanding (Basic)
44.26M 42.88M 42.08M 41.22M
Shares Outstanding (Diluted)
44.26M 42.88M 42.08M 41.22M
EPS (Basic)
-0.23 -0.51 -0.65 -0.68
EPS (Diluted)
-0.23 -0.51 -0.65 -0.68
EBITDA
6.08M -13.33M -23.47M -20.89M
EBIT
-1.76M -18.88M -28.32M -25.63M
Depreciation & Amortization
7.84M 5.55M 4.85M 4.74M